Vol 91, No 12 (2020)
Research paper
Published online: 2020-11-24

open access

Page views 3582
Article views/downloads 2343
Get Citation

Connect on Social Media

Connect on Social Media

COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis

Elias Ortiz Molina1, Rafael Hernandez Pailos1, Maria Pola Guillen1, Ana Pascual Pedreno1, Eduardo Rodriguez Rodriguez1, Antonio Hernandez Martinez2
Pubmed: 33447995
Ginekol Pol 2020;91(12):755-763.

Abstract

Objectives: Determine the strengths and weakness of a symptomatic screening for COVID-19 in pregnant women. Analyze
the clinical presentation, management, and outcomes. Design: Descriptive retrospective observational study. Setting:
Mancha-Centro Hospital (Spain).
Material and methods: Population: Symptomatic pregnant women with confirmed diagnosis of COVID-19. Between the 12th
of March and 17th of April 2020, all the symptomatic pregnancies were screened with diagnostic test for SARS-CoV-2. Data
collection was done by reviewing the medical records and telephone interviews. Main outcome measures: Clinical characteristics,
management, treatment, and obstetric and neonatal outcomes.
Results: Twenty patients with positive COVID-19 diagnostic test out of thirty-four suspected. The most common symptoms
were fever (70%), cough (65%) and myalgia (35%). A unique symptom of presentation in 20% of cases. COVID-19 pneumonia
was diagnosed in 30% by chest X-ray and one case had pulmonary embolism associated diagnosed by CT-Scan. Thromboprophylaxis
was indicated in 16 out of 20 patients. Eight women finished their pregnancy during the observation period.
Type of birth: 25% natural birth, 12.5% assisted vaginal delivery and 62.5% caesarean section. We had three severe cases,
two of them with intensive care support. All neonates had negative test for COVID 19 infection.
Conclusions: We recommend universal screening of all pregnant woman for COVID-19 during the pandemic because of
the limits of the symptomatic screening seen in this studio and the ratio of asymptomatic pregnancies with positive test
for COVID-19 recently published.

Article available in PDF format

View PDF Download PDF file

References

  1. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 (9.04.2020).
  2. WHO Timeline - COVID-19. https://www.who.int/news-room/detail/08-04-2020-who-timeline---covid-19 (9.04.2020).
  3. COVID-19 Map - Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html (25.04.2020).
  4. Evolución de coronavirus COVID-19 en Castilla-La Mancha | Servicio de Salud de Castilla-La Mancha. https://sanidad.castillalamancha.es/ciudadanos/enfermedades-infecciosas/coronavirus/evolucion-de-coronavirus-covid-19-en-castilla-la-mancha (26.04.2020).
  5. Breslin N, Baptiste C, Miller R, et al. COVID-19 in pregnancy: early lessons. Am J Obstet Gynecol MFM. 2020: 100111.
  6. Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020; 99(7): 823–829.
  7. Ferrazzi EM, Frigerio L, Cetin I, et al. COVID-19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome. Int J Gynaecol Obstet. 2020; 149(3): 377–378.
  8. Yan J, Guo J, Fan C, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020; 223(1): 111.e1–111.e14.
  9. Li Na, Han L, Peng M, et al. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study. Clin Infect Dis. 2020.
  10. Poon LC, Yang H, Kapur A, et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals. Int J Gynaecol Obstet. 2020; 149(3): 273–286.
  11. Boelig RC, Manuck T, Oliver EA, et al. Labor and delivery guidance for COVID-19. Am J Obstet Gynecol MFM. 2020; 2(2): 100110.
  12. Saccone G, Carbone FI, Zullo F. The novel coronavirus (2019-nCoV) in pregnancy: What we need to know. Eur J Obstet Gynecol Reprod Biol. 2020; 249: 92–93.
  13. Qi H, Luo X, Zheng Y, et al. Safe delivery for pregnancies affected by COVID-19. BJOG. 2020; 127(8): 927–929.
  14. Favre G, Pomar L, Qi X, et al. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis. 2020; 20(6): 652–653.
  15. Di Renzo GC, Giardina I. COVID-19 in Pregnancy: Consider Thromboembolic Disorders and Thromboprophylaxis. Am J Obstet Gynecol. 2020: S0002-9378(20)30465-8.
  16. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020; 18(5): 1023–1026.
  17. SEGO | Sociedad Española de Ginecología y Obstetricia. Posicionamiento SEGO sobre profilaxis de la enfermedad tromboembólica en el puerperio de pacientes COVID-19. https://sego.es/MasCovid-19 (15.04.2020).
  18. Shoushtari A, Nugent K. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. The Southwest Respiratory and Critical Care Chronicles. 2020; 8(33): 1–6.
  19. Mortality Analyses - Johns Hopkins Coronavirus Resource Cente. https://coronavirus.jhu.edu/data/mortality (28.04.2020).
  20. Considerations for Inpatient Obstetric Healthcare Settings | CDC. https://www.cdc.gov/coronavirus/2019-ncov/hcp/inpatient-obstetric-healthcare-guidance.html (15.04.2020).
  21. Sutton D, Fuchs K, D'Alton M, et al. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. N Engl J Med. 2020; 382(22): 2163–2164.
  22. Vintzileos WS, Muscat J, Hoffmann E, et al. Screening all pregnant women admitted to Labor and Delivery for the virus responsible for 1 COVID-19 2. Am J Obstet Gynecol. 2020: S0002-9378(20)30472-5.
  23. Cheng MP, Papenburg J, Desjardins M, et al. Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review. Ann Intern Med. 2020; 172(11): 726–734.
  24. Guan WJ, Ni ZY, Hu Yu, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18): 1708–1720.
  25. Wang D, Hu Bo, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061–1069.
  26. Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology. 2020; 58(3): 295–298.
  27. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8): 2251–2261.
  28. Vaira LA, Salzano G, Deiana G, et al. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020; 130(7): 1787.
  29. Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(6): 1421–1424.
  30. Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–847.
  31. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054–1062.
  32. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239–1242.
  33. Ferrazzi E, Frigerio L, Savasi V, et al. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis. BJOG. 2020 [Epub ahead of print].